PH rollout of Sputnik V jabs to proceed despite Brazil rejection

The Philippine rollout of the Sputnik V vaccine will proceed as planned despite Brazil's rejection.

DOH Undersecretary Maria Rosario Vergeire stated that the FDA has granted Emergency Use Authorization to Sputnik V, deeming it safe for public use.

Gamaleya, the manufacturer of Sputnik V, is responsible for reporting any adverse effects to the Philippine FDA.

Malacañang expressed confidence in the safety and effectiveness of Sputnik V vaccines after they passed through the FDA process.